← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $712K of BioMarin Pharmaceutical Inc.

Sold$712,388
$85.49Price
8,333Shares
−2%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Wed, Jan 27. Filed Thu, Jan 28, 7:35 PM ET, after the close. Not investment advice.